Die Übersetzung dieser Seite ist experimentell und in Entwicklung. Wir freuen uns über Ihr !

Embla Medical hf Zukünftiges Wachstum

Future Kriterienprüfungen 2/6

Embla Medical hf wird ein jährliches Gewinn- und Umsatzwachstum von 17.4% bzw. 8.3% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 17.1% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 10.6% betragen.

Wichtige Informationen

17.3%

Wachstumsrate der Gewinne

17.1%

EPS-Wachstumsrate

Medical Equipment Gewinnwachstum	18.2%
Wachstumsrate der Einnahmen	8.3%
Zukünftige Eigenkapitalrendite	10.6%
Analystenabdeckung	Low
Zuletzt aktualisiert	27 May 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Embla Medical hf. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Apr 26

Recent updates

Market Participants Recognise Embla Medical hf.'s (CPH:EMBLA) Earnings

May 14

Embla Medical hf. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Apr 26

These 4 Measures Indicate That Össur hf (CPH:OSSR) Is Using Debt Reasonably Well

Dec 22

There Are Reasons To Feel Uneasy About Össur hf's (CPH:OSSR) Returns On Capital

Dec 07

Are Investors Undervaluing Össur hf. (CPH:OSSR) By 37%?

Sep 21

Returns On Capital Signal Tricky Times Ahead For Össur hf (CPH:OSSR)

Sep 02

Össur hf (CPH:OSSR) Seems To Use Debt Quite Sensibly

Aug 16

Össur hf.'s (CPH:OSSR) Intrinsic Value Is Potentially 42% Above Its Share Price

Jun 16

Össur hf (CPH:OSSR) Will Want To Turn Around Its Return Trends

Jun 01

Does Össur hf (CPH:OSSR) Have A Healthy Balance Sheet?

May 08

Össur hf (CPH:OSSR) Will Be Hoping To Turn Its Returns On Capital Around

Feb 22

Analysts Have Made A Financial Statement On Össur hf.'s (CPH:OSSR) Yearly Report

Feb 03

Calculating The Fair Value Of Össur hf. (CPH:OSSR)

Nov 25

Returns On Capital Signal Tricky Times Ahead For Össur hf (CPH:OSSR)

Oct 17

Is Össur hf (CPH:OSSR) A Risky Investment?

Sep 28

Calculating The Fair Value Of Össur hf. (CPH:OSSR)

Aug 21

Össur hf (CPH:OSSR) Might Be Having Difficulty Using Its Capital Effectively

Jul 11

Here's Why Össur hf (CPH:OSSR) Can Manage Its Debt Responsibly

May 28

Calculating The Fair Value Of Össur hf. (CPH:OSSR)

May 07

There Are Reasons To Feel Uneasy About Össur hf's (CPH:OSSR) Returns On Capital

Mar 25

We Think The Compensation For Össur hf.'s (CPH:OSSR) CEO Looks About Right

Mar 02

We Think Össur hf (CPH:OSSR) Can Stay On Top Of Its Debt

Feb 22

Does The Market Have A Low Tolerance For Össur hf.'s (CPH:OSSR) Mixed Fundamentals?

Feb 09

What Kind Of Shareholders Own Össur hf. (CPH:OSSR)?

Jan 26

Össur hf (CPH:OSSR) Shareholders Have Enjoyed An Impressive 115% Share Price Gain

Jan 08

We're Watching These Trends At Össur hf (CPH:OSSR)

Dec 21

Gewinn- und Umsatzwachstumsprognosen

CPSE:EMBLA - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (USD Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2026	1,018	103	111	151	4
12/31/2025	945	87	98	136	5
12/31/2024	869	72	30	107	4
3/31/2024	804	57	47	93	N/A
12/31/2023	786	58	52	94	N/A
9/30/2023	766	52	43	82	N/A
6/30/2023	750	45	37	72	N/A
3/31/2023	730	43	28	57	N/A
12/31/2022	719	43	35	61	N/A
9/30/2022	715	47	49	76	N/A
6/30/2022	719	57	50	79	N/A
3/31/2022	728	62	69	96	N/A
12/31/2021	719	64	74	101	N/A
9/30/2021	701	50	54	77	N/A
6/30/2021	692	48	63	84	N/A
3/31/2021	637	11	62	82	N/A
12/31/2020	630	6	68	92	N/A
9/30/2020	639	20	65	92	N/A
6/30/2020	635	19	78	109	N/A
3/31/2020	680	59	75	109	N/A
12/31/2019	686	66	63	95	N/A
9/30/2019	675	83	72	102	N/A
6/30/2019	652	85	55	84	N/A
3/31/2019	631	83	47	76	N/A
12/31/2018	613	80	39	69	N/A
9/30/2018	599	69	48	78	N/A
6/30/2018	593	64	44	71	N/A
3/31/2018	579	58	48	72	N/A
12/31/2017	569	58	N/A	74	N/A
9/30/2017	553	49	N/A	64	N/A
6/30/2017	543	51	N/A	68	N/A
3/31/2017	538	52	N/A	61	N/A
12/31/2016	521	51	N/A	66	N/A
9/30/2016	507	49	N/A	69	N/A
6/30/2016	495	50	N/A	65	N/A
3/31/2016	483	51	N/A	74	N/A
12/31/2015	483	51	N/A	66	N/A
9/30/2015	488	54	N/A	67	N/A
6/30/2015	497	55	N/A	77	N/A
3/31/2015	502	57	N/A	79	N/A
12/31/2014	509	59	N/A	85	N/A
9/30/2014	509	58	N/A	86	N/A
6/30/2014	487	55	N/A	82	N/A
3/31/2014	460	46	N/A	71	N/A
12/31/2013	436	40	N/A	66	N/A
9/30/2013	406	35	N/A	59	N/A
6/30/2013	400	33	N/A	49	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: EMBLADas prognostizierte Gewinnwachstum (17.4% pro Jahr) liegt über der Sparquote (0.9%).

Ertrag vs. Markt: EMBLADie Erträge des Unternehmens (17.4% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Danish (12.8% pro Jahr).

Hohe Wachstumserträge: EMBLADie Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.

Einnahmen vs. Markt: EMBLADie Einnahmen des Unternehmens (8.3% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt Danish (11.1% pro Jahr).

Hohe Wachstumseinnahmen: EMBLADie Einnahmen des Unternehmens (8.3% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: EMBLADie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (10.6 %).

Embla Medical hf Zukünftiges Wachstum

Future Kriterienprüfungen 2/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Embla Medical hf. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Össur hf. Provides Earnings Guidance for the Year 2024

Össur hf. Reaffirms Financial Guidance for the Year 2023

Consensus EPS estimates fall by 12%

Össur hf. Provides Earnings Guidance for the Year 2023

Consensus EPS estimates fall by 23%

Recent updates

Market Participants Recognise Embla Medical hf.'s (CPH:EMBLA) Earnings

Embla Medical hf. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

First quarter 2024 earnings released: EPS: US$0.019 (vs US$0.024 in 1Q 2023)

New minor risk - Financial position

A Look At The Fair Value Of Embla Medical hf. (CPH:OSSR)

Is Össur hf (CPH:OSSR) Using Too Much Debt?

Össur hf. Appoints Caroline Vagner Rosenstand to the Audit Committee

Investor sentiment improves as stock rises 15%

Full year 2023 earnings: EPS misses analyst expectations

Össur hf. Provides Earnings Guidance for the Year 2024

Why Investors Shouldn't Be Surprised By Össur hf.'s (CPH:OSSR) P/E

Calculating The Intrinsic Value Of Össur hf. (CPH:OSSR)

Össur hf. to Report Q1, 2024 Results on Apr 23, 2024

Össur hf., Annual General Meeting, Mar 12, 2025

Össur hf (CPH:OSSR) Seems To Use Debt Quite Sensibly

Returns On Capital Signal Tricky Times Ahead For Össur hf (CPH:OSSR)

Third quarter 2023 earnings released: EPS: US$0.033 (vs US$0.016 in 3Q 2022)

Össur hf. Reaffirms Financial Guidance for the Year 2023

A Look At The Fair Value Of Össur hf. (CPH:OSSR)

We Think Össur hf (CPH:OSSR) Is Taking Some Risk With Its Debt

Second quarter 2023 earnings: EPS misses analyst expectations

Össur hf (CPH:OSSR) May Have Issues Allocating Its Capital

Össur hf. Announces Executive Changes

Össur hf.'s (CPH:OSSR) Intrinsic Value Is Potentially 19% Below Its Share Price

Össur hf (CPH:OSSR) Seems To Use Debt Quite Sensibly

First quarter 2023 earnings released: EPS: US$0.024 (vs US$0.022 in 1Q 2022)

Össur hf (CPH:OSSR) Might Be Having Difficulty Using Its Capital Effectively

Consensus EPS estimates fall by 12%

Full year 2022 earnings: Revenues in line with analyst expectations

Össur hf. Provides Earnings Guidance for the Year 2023

A Look At The Intrinsic Value Of Össur hf. (CPH:OSSR)

Össur hf. to Report Q1, 2023 Results on Apr 25, 2023

These 4 Measures Indicate That Össur hf (CPH:OSSR) Is Using Debt Reasonably Well

There Are Reasons To Feel Uneasy About Össur hf's (CPH:OSSR) Returns On Capital

Less than half of directors are independent

Consensus EPS estimates fall by 23%

Third quarter 2022 earnings released: EPS: US$0.016 (vs US$0.041 in 3Q 2021)

Investor sentiment improved over the past week

Are Investors Undervaluing Össur hf. (CPH:OSSR) By 37%?

Returns On Capital Signal Tricky Times Ahead For Össur hf (CPH:OSSR)

Össur hf. (CPSE:OSSR) acquired Naked Prosthetics.

Össur hf (CPH:OSSR) Seems To Use Debt Quite Sensibly

Second quarter 2022 earnings released: EPS: US$0.034 (vs US$0.046 in 2Q 2021)

Price target decreased to kr.42.00

Össur hf. Revises Earnings Guidance for the Year 2022

Össur hf. Reports Preliminary Earnings Results for the Second Quarter and First Half of 2022

Össur Appoints Gudny Arna Sveinsdottir as Chief Financial Officer, Effective September 1, 2022

Price target decreased to kr.43.70

Össur hf.'s (CPH:OSSR) Intrinsic Value Is Potentially 42% Above Its Share Price

Now 22% undervalued after recent price drop

Össur hf (CPH:OSSR) Will Want To Turn Around Its Return Trends

Does Össur hf (CPH:OSSR) Have A Healthy Balance Sheet?

Now 20% undervalued after recent price drop

First quarter 2022 earnings: EPS and revenues miss analyst expectations

Less than half of directors are independent

Össur Hf. Announces New R&D Leadership

Össur hf (CPH:OSSR) Will Be Hoping To Turn Its Returns On Capital Around

Össur Launches New POWER KNEE

Analysts Have Made A Financial Statement On Össur hf.'s (CPH:OSSR) Yearly Report

Full year 2021 earnings: EPS misses analyst expectations

Össur hf. Announces Sales Guidance for the Full Year 2022

Calculating The Fair Value Of Össur hf. (CPH:OSSR)

Third quarter 2021 earnings released: EPS US$0.041 (vs US$0.035 in 3Q 2020)

Returns On Capital Signal Tricky Times Ahead For Össur hf (CPH:OSSR)

Is Össur hf (CPH:OSSR) A Risky Investment?

Calculating The Fair Value Of Össur hf. (CPH:OSSR)

Össur Hf. Announces Earnings Guidance for the Full Year 2021

Second quarter 2021 earnings released: EPS US$0.046 (vs US$0.042 loss in 2Q 2020)

Össur hf (CPH:OSSR) Might Be Having Difficulty Using Its Capital Effectively